Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Financial Performance and Segment Highlights
HOLX logo

Hologic's Revenues Hit $1.02B with 5% Diagnostics Surge Amid Skeletal Setbacks

HOLX10-QFiling Date: 2/6/2025
Hologic, Inc.
Description

What this story covers

Hologic reported $1.02B Q1 revenue, up 0.9%, driven by 5% diagnostics growth to $471M; services rose 10%. Acquisitions like Endomag ($314M) and Gynesonics ($350M) bolster breast and GYN segments. Operating income up 16% to $230M; cash flow $189M supports buybacks. Skeletal Health down 38% from compliance halt, expected resolution in 2025. Strong liquidity at $1.78B cash.

Story snapshot

CompanyHologic, Inc.
TickerHOLX
VariantStandard detailed
Duration13:26
Filing type10-Q
PeriodQ1 2025
IndustryHealthcare & Pharmaceuticals
Accession0000859737-25-000005

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in